Status:
ENROLLING_BY_INVITATION
The Effect of Complex Decongestıve Therapy on Oxıdatıve Stress and Antıoxıdants
Lead Sponsor:
Baskent University
Conditions:
What Are the Effects of Lymphedema Treatment
Eligibility:
FEMALE
25+ years
Phase:
NA
Brief Summary
It is aimed to determine the changes of complex decongestive therapy applications on oxidative stress parameters and antioxidants in patients with lymphedema after breast cancer treatment.
Detailed Description
Lymphedema, which is the most common late complication of patients undergoing cancer treatment, affects the physical, social and psychological lives of the individual and decreases the quality of life...
Eligibility Criteria
Inclusion
- Development of lymphedema after breast cancer treatment
- Clinical stage of lymphedema Stage-2 or Stage-3 diagnosis
Exclusion
- Receiving treatment for lymphedema in the last three months
- Those diagnosed with severe heart failure and/or arrhythmia
- Persistent infection in the affected extremities
- Ongoing chemotherapy treatment
- Diagnosed with liver disease
Key Trial Info
Start Date :
April 3 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 3 2028
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT06572098
Start Date
April 3 2024
End Date
April 3 2028
Last Update
September 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Baskent University
Adana, çukurova, Turkey (Türkiye), 01250